Oppenheimer Asset Management’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.15M | Sell |
|
|||||
|
2025
Q1 | $8.21M | Sell |
|
|||||
|
2024
Q4 | $5.72M | Buy |
|
|||||
|
2024
Q3 | $6.83M | Buy |
|
|||||
|
2024
Q2 | $3.84M | Buy |
|
|||||
|
2024
Q1 | $2.83M | Buy |
|
|||||
|
2023
Q4 | $3M | Buy |
|
|||||
|
2023
Q3 | $2.48M | Buy |
|
|||||
|
2023
Q2 | $2.11M | Buy |
|
|||||
|
2023
Q1 | $2.45M | Buy |
|
|||||
|
2022
Q4 | $2.48M | Sell |
|
|||||
|
2022
Q3 | $1.61M | Sell |
|
|||||
|
2022
Q2 | $1.98M | Buy |
|
|||||
|
2022
Q1 | $2.25M | Sell |
|
|||||
|
2021
Q4 | $3.59M | Buy |
|
|||||
|
2021
Q3 | $4.71M | Buy |
|
|||||
|
2021
Q2 | $4.45M | Buy |
|
|||||
|
2021
Q1 | $4.33M | Sell |
|
|||||
|
2020
Q4 | $3.46M | Buy |
|
|||||
|
2020
Q3 | $3.71M | Buy |
|
|||||
|
2020
Q2 | $2.35M | Buy |
|
|||||
|
2020
Q1 | $1.52M | Buy |
|
|||||
|
2019
Q4 | $276K | Sell |
|
|||||
|
2019
Q3 | $236K | Sell |
|
|||||
|
2019
Q2 | $245K | Sell |
|
|||||
|
2019
Q1 | $302K | Sell |
|
|||||
|
2018
Q4 | $399K | Sell |
|
|||||
|
2018
Q3 | $490K | Buy |
|